Yuhan Corporation (KRX:000105)

Market Cap	5.97T -33.3%
Revenue (ttm)	2.28T +5.4%
Net Income	234.09B +195.3%
EPS	3,139.61 +193.3%
Shares Out	n/a
PE Ratio	21.47
Forward PE	47.60
Dividend	610.00 (0.91%)
Ex-Dividend Date	Feb 26, 2026

Volume	227
Open	67,500
Previous Close	67,500
Day's Range	66,900 - 68,800
52-Week Range	55,100 - 115,300
Beta	0.40
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 12, 2027

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1926
• Employees: 2,082
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000105

Financial Performance

In 2025, Yuhan's revenue was 2.19 trillion, an increase of 5.75% compared to the previous year's 2.07 trillion. Earnings were 191.09 billion, an increase of 170.33%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error